Paragraph IV Disputes

Over 80% of drug manufacturers are unprepared to meet the legal challenges of more than $60 billion in pharmaceutical patent losses.

Is your company one of them?

Avoid being caught off guard by attending the only event dedicated to providing brand name and generic legal professionals like you with the tools needed to master the strategies, standards and tactics of Paragraph IV litigation.

Brand name and generic pharmaceutical companies are beginning to feel the initial impact of the patent cliff: the pecuniary perils of patent loss and the economic consequences associated with the decline of Hatch-Waxman market exclusivity. As a result, the industry has entered an era of “extreme” Paragraph IV litigation where the monetary ante has never been higher.

To help you respond to the challenges of this new era, ACI’s 6th Annual Paragraph IV Disputes conference will guarantee your access to the leading legal minds in this area. A “who’s who” of Hatch-Waxman litigators — for both brand names and generics — will help you conquer the patent crisis of 2012 by addressing such industry shaping topics as:

• The impact of the AIA on Hatch –Waxman litigation
• Carve-outs, use codes and labeling
• Claim construction
• Prior art obviousness and obvious-type double patenting
• Inducement of infringement and divided infringement
• Inequitable conduct
• Damages

Hear also from renowned federal jurists and a key official from the Federal Trade Commission. Learn firsthand how the bench analyzes the theories of your case and what the FTC deems as “fair and foul” in the settlement of pharmaceutical patent disputes.

Complete your professional training by attending one or more of these customized Working Groups, Workshops and Master Classes:

Hatch-Waxman and BPCIA 101 — A Primer on IP Basics and Regulatory Fundamentals which will provide the patent and regulatory backdrop for the more in-depth Hatch-Waxman litigation controversies discussed in the main conference;

A Working Group Session on Assessing The Impact of New PTO Procedures Under the AIA on Paragraph IV Litigation which will address how new pre- and post issuance procedures may alter certain components of Paragraph IV litigation and parallel proceedings between the Federal Courts and PTO; and

The Master Class on Settling Paragraph IV Disputes: Drafting and Negotiating Strategies for Brand-Names and Generics which will give practical and hands-on strategies for drafting and negotiating settlement agreements that will pass muster with the FTC.

In this costly and ruthless endgame, not a moment can be lost. Register now by calling 1-888-224-2480, faxing your registration form to 1-877-927-1563 or logging on to www.AmericanConference.com/PIVDisputesNYC

Supporting Sponsors:

Cocktail Reception Host:

Luncheon Sponsor:

Associate Sponsor:

VIP Breakfast Sponsor:

Executive Sponsor:

Sponsored by:

Media Partners:

- Actions -

- Share -